nivolumab,ipilimumab
bms
['nivo', 'scandium', 'ipilimumab', 'melanoma', 'scandium 2', 'nivolumab']
a phase i, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the scandium 2 trial). roger olofsson bagge 
Professor in Cancer Surgery at Sahlgrenska University Hospital. @sahlgrenska @SahlgrenskaAcad @goteborgUni #wcmtm #melanoma #breastcancer #surgery